USPTO serial 76562555
Serial No. 76562555
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SPRUILL, DARRYL M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 76562555?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cory M. Amron
REID M WILSON VORYS, SATER, SEYMOUR & PEASE LLP1828 L ST 11TH FLWASHINGTON, DC 20036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed synthetic resins for use in a wide variety of fields, unprocessed plastic materials in powder, liquid or paste form for use in a wide variety of fields; manures; compost; fire extinguishing compositions; tempering and soldering preparations, chemical substances for preserving foodstuffs, tanning substances, namely, tanning agents for use in the manufacture of leather; adhesives for general industrial use | ACTIVE | — |
| 005 | Pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction, pharmaceutical preparations namely, anticoagulants, pharmaceutical preparations namely, antidepressants; pharmaceutical preparations namely, appetite suppressants; pharmaceutical preparations for use in chemotherapy, pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; veterinary preparations, namely, pain relief medication; veterinary preparations for treatment of intestinal bacteria; veterinary vaccine for horses; veterinary vaccines; veterinary vaccines for bovine, sheep, horse, cat, dog, chicken; yeast or yeast extracts for medical, veterinary or pharmaceutical purposes; sanitary preparations for medical purposes, namely, sanitizers for hospital and household use and for use in institutional and industrial areas; deodorants other than for personal use, namely, air deodorant, car deodorant, and household deodorant; dietetic substances adapted for medical use, namely, bee pollen for use as a dietary food supplement, dietary drink mix for use as a meal replacement, dietary food supplements, dietary supplemental drinks, dietary supplements, lecithin for use as a dietary supplement, meal replacement and dietary supplement drink mixes, nutraceuticals for use as a dietary supplement, and wheat for use as a dietary supplement; food for babies; medical plasters; wound, burn, and surgical dressing materials; material for stopping teeth; dental wax; all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic and agricultural use, herbicides for domestic and agricultural use | ACTIVE | — |
| 017 | Rubber, gutta-percha, gum, asbestos, mica and goods made from these materials and not included in other classes, namely, natural rubber, nitrile rubber, packing padding of rubber for shipping containers, polysulfide rubber, reclaimed rubber, rings of rubber for use as pipe connection seals, raw or semi-worked rubber, rubber bags for merchandise packaging in the nature of envelopes or pouches, rubber bands for commercial and industrial uses, rubber bars and rods, rubber bottle stoppers, rubber bumpers for loading docks, rubber chips or granules for use as a playground ground cover, rubber clack valves for industrial use, rubber cords and laces, rubber derivatives, rubber for use in the manufacture of tires, cable, paper, rubber hose for use in connection with welding, rubber lids and caps for industrial packaging containers, rubber packing for shipping containers, rubber padding for shipping containers, rubber sealant for caulking and adhesive purposes, rubber sheets, rubber shock absorbers for industrial machinery, rubber sleeves for protecting parts of machinery, rubber stoppers for industrial packaging containers, rubber thread not for textile use, rubber thread and covered rubber yarn not for textile use, rubber tubes and pipes, shock absorbing rubber buffers for industrial machinery, shock buffers of rubber for industrial machinery, silicone rubber, sleeves of rubber for protecting parts of machinery, stuffing of rubber, styrene-butadiene rubber, synthetic rubber, synthetic rubber for use in the manufacture of tires, cable, paper, valves of rubber or vulcanized fiber not including machine elements, and washers of rubber or vulcanized fiber; and plastics in the form of powders, pastes, liquids, fibres, capillarities, emulsions, pellets, granules, films, sheets, plates, blocks, rods and pipes including flexible pipes not of metal, all for further industrial and agricultural use or manufacture; electrical, thermal and acoustic insulating materials for buildings and construction; padding materials of rubber and plastics for packing use and/or for tightly fixing purposes; floating anti-pollution barriers, namely, barrier curtains in the nature of floating baffles or booms for the containment of pollutants | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mitsui Chemicals, Inc.
- Other trademarks owned by Mitsui Chemicals, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 017
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 11, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 10, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 18, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 28, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 23, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 23, 2005 | ALIE | ASSIGNED TO LIE | — |
| Aug 12, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 9, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 2, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 2, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 14, 2005 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 14, 2005 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 23, 2005 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 16, 2005 | CWBP | WITHDRAWN BEFORE PUBLICATION | — |
| Feb 17, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 17, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 28, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 6, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Dec 17, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 17, 2004 | PAPER RECEIVED | — | |
| Jun 21, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 24, 2003 | NWAP | NEW APPLICATION ENTERED | — |